Delisting Shedir Pharma, OPA: threshold of 95% of share capital reached

Italy ETFs weigh 2 on retail managed savings Focus on

(Finance) – With reference topublic takeover offer (OPA) fully voluntary, concerning a maximum of 1,362,500 ordinary shares of Shedir Pharmaa group listed on Euronext Growth Milan and active in the field of nutraceuticals and pharmaceuticals, Dimainvest announces that, as a result of the acceptances to the offer received up to today, 9 January 2025, it will hold a stake of more than 95% of the share capital.

Therefore, it turns out the Condition of Effectiveness of the Offer has been fulfilled – consisting in reaching a threshold of acceptances such as to allow the Offeror to hold a stake equal to at least 95% of the Issuer’s share capital – with consequent completion of the same.

The acceptance period for the offer will end tomorrow, January 10, 2025 (included), at 5.30 pm (Italian time), unless the acceptance period is extended.

(Photo: Jason Briscoe on Unsplash)

tlb-finance